Mahmuda Yeasmin
Dhaka, C, Bangladesh
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity.
Journal: Journal of virology
Published: March 27, 2026
Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
Journal: Virology
Published: November 04, 2025
Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
Journal: Virology
Published: November 04, 2025
Metatranscriptomic insights into host-microbiome interactions underlying asymptomatic COVID-19 cases.
Journal: Scientific reports
Published: August 25, 2025
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
Journal: Journal of virology
Published: April 23, 2025
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
Journal: Virology
Published: January 05, 2025
Current deadly dengue outbreak and serotype displacements in Bangladesh in 2023.
Journal: Indian journal of medical microbiology
Published: March 24, 2024
Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: A systematic review.
Journal: New microbes and new infections
Published: September 29, 2023
Predominant dengue virus serotype in Dhaka, Bangladesh: A research letter on samples from 2022 outbreak.
Journal: Health science reports
Published: August 14, 2023
Spike protein mutations and structural insights of pangolin lineage B.1.1.25 with implications for viral pathogenicity and ACE2 binding affinity.
Journal: Scientific reports
Published: May 22, 2023
Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2.
Journal: Vaccines
Published: October 20, 2022
Last Updated: 09/26/2026